A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis
<p>Abstract</p> <p>Background</p> <p>To reduce injection pain and improve satisfaction, a thinner (29-gauge [29G]), sharper (5-bevel) needle than the 27G/3-bevel needle used previously to inject interferon (IFN) beta-1a, 44 or 22 mcg subcutaneously (sc) three times week...
Main Authors: | Prais Wes A, Vedrine Lionel, Bozzato Gian B, Jaber Amer, Berube Julie, Laurent Philippe E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | BMC Neurology |
Online Access: | http://www.biomedcentral.com/1471-2377/8/38 |
Similar Items
-
QUALITY OF LIFE IN ADOLESCENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA-1A FOR SUBCUTANEOUS INJECTION
by: A.N. Platonova, et al.
Published: (2009-01-01) -
QUALITY OF LIFE IN ADOLESCENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA-1A FOR SUBCUTANEOUS INJECTION
by: A.N. Platonova, et al.
Published: (2009-03-01) -
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
by: Mark S. Freedman, et al.
Published: (2024-01-01) -
Interferon-beta injection site reactions in patients with multiple sclerosis
by: Martina Maurelli, et al.
Published: (2018-11-01) -
The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
by: Ebers, G, et al.
Published: (1997)